-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JljRglyOLL30peOqIiRJOvWRJzLaEDwe9YSUblI+PRhO8Twp04FCDYJ8/mtfdvBd +lVYHrR9Iagz8pfa/pkAtw== 0001230295-06-000005.txt : 20060103 0001230295-06-000005.hdr.sgml : 20060102 20060103164055 ACCESSION NUMBER: 0001230295-06-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051230 FILED AS OF DATE: 20060103 DATE AS OF CHANGE: 20060103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TENDLER DAVID CENTRAL INDEX KEY: 0001210437 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 06502965 MAIL ADDRESS: STREET 1: 120 EAST END AVE CITY: NEW YORK STATE: NY ZIP: 10028 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 ten33.xml X0202 4 2005-12-30 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001210437 TENDLER DAVID C/O TENDLER BERETZ, LLC 150 E. 52ND STREET, 16TH FLOOR NEW YORK NY 10022 1 0 0 0 Common Stock, $.01 par value per share 2005-12-30 4 A 0 1002 3.7400 A 23840.00 D Option to Purchase Common Stock, $.01 par value 3.7400 2005-12-30 4 A 0 5000 3.7400 A 2006-12-30 2016-12-30 Common Stock, $.01 par value per share 5000.00 5000.00 D These shares were granted pursuant to the Company's 2004 Incentive Plan, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $3,750.00, until he is no longer an Outside Director. On December 30, 2005, the fair market value of the Common Stock, based on the closing price, was $3.74. These options will become fully vested and immediately exercisable on 12/30/2006. By: Beata A. Smith as Attorney-In-Fact for 2006-01-03 -----END PRIVACY-ENHANCED MESSAGE-----